NIH-funded research R01 grant

Germline clues to skin-related immune side effects from cancer immunotherapy

Official title: Discovering and characterizing the germline mechanisms of cutaneous immune-related adverse events (cirAE)

Funded at University of Tx Md Anderson Can Ctr · NIH-11606584 · Data updated 2026-11-12

This grant looks for genetic clues in people treated with immune checkpoint inhibitors to understand why some develop skin-related immune side effects.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 22, 2026
Project endAugust 31, 2030
Funding year2026
Award (this year)$669,309
NIH project number7R01AR085629-02
Project IDNIH-11606584 on NIH RePORTER

Who could benefit from this research

Could help

Adults with cancer who are receiving or have received immune checkpoint inhibitor therapy and have or are at risk for cutaneous irAEs.

Less likely to help

Patients without irAEs or not treated with ICIs may not directly benefit.

What this research studies

Researchers will analyze germline DNA from thousands of cancer patients who received immune checkpoint inhibitors to find genetic variants linked to cutaneous immune-related adverse events. They will combine these genetic findings with spatial and longitudinal molecular data to map when and how these skin reactions occur. The project also aims to identify the exact genes and biological pathways causing cirAEs and to see how these variants might influence anti-tumor responses and survival. A prospective molecular phenotyping effort will trace the mechanisms of cirAE risk over time and in different body contexts.

Why it matters

Potential benefit: Better prediction and understanding of who is at risk for skin-related side effects from immunotherapy, potentially leading to safer, more personalized cancer treatment.

How similar studies have gone: This area is exploratory with limited prior germline studies on cirAEs, making findings potentially novel.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Leboeuf, Nicole R — University of Tx Md Anderson Can Ctr
  • Study coordinator: Leboeuf, Nicole R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.